J-code: Drugs administered other than oral method; chemotherapy drugs Drugs administered other than oral method; chemotherapy drugs
1,255 codes
Billing context
J-codes are permanent national codes for drugs and biologicals — most often clinician-administered (buy-and-bill) products paid under Medicare Part B — plus certain immunosuppressive, inhalation (via DME), and oral anticancer/antiemetic drugs. Units are reported in multiples of the dosage in the code descriptor.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| J3121 | Injection, testosterone enanthate, 1 mg | $0.052per 1 MG | Jan 1, 2015 | Active |
| J3130 | Injection, testosterone enanthate, up to 200 mg | — | Jan 1, 1982 | Ended Dec 31, 2014 |
| J3140 | Injection, testosterone suspension, up to 50 mg | — | Jan 1, 1982 | Ended Dec 31, 2014 |
| J3145 | Injection, testosterone undecanoate, 1 mg | $2.203per 1 MG | Jan 1, 2015 | Active |
| J3150 | Injection, testosterone propionate, up to 100 mg | — | Jan 1, 1982 | Ended Dec 31, 2014 |
| J3230 | Injection, chlorpromazine hcl, up to 50 mg | $16.802per 50 MG | Jan 1, 1982 | Active |
| J3240 | Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial | $2,155.112per 0.9 MG | Jan 1, 1986 | Active |
| J3241 | Injection, teprotumumab-trbw, 10 mg | $381.627per 10 MG | Oct 1, 2020 | Active |
| J3243 | Injection, tigecycline, 1 mg | $0.479per 1 MG | Jan 1, 2007 | Active |
| J3244 | Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg | — | Jan 1, 2023 | Active |
| J3245 | Injection, tildrakizumab, 1 mg | $120.965per 1 MG | Jan 1, 2019 | Active |
| J3246 | Injection, tirofiban hcl, 0.25 mg | $2.615per 0.25 MG | Jan 1, 2005 | Active |
| J3247 | Injection, secukinumab, intravenous, 1 mg | $18.131per 1 MG | Jul 1, 2024 | Active |
| J3250 | Injection, trimethobenzamide hcl, up to 200 mg | $62.418per 200 MG | Jan 1, 1982 | Active |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | $2.345per 80 MG | Jan 1, 1982 | Active |
| J3262 | Injection, tocilizumab, 1 mg | $5.325per 1 MG | Jan 1, 2011 | Active |
| J3263 | Injection, toripalimab-tpzi, 1 mg | $40.658per 1 MG | Jul 1, 2024 | Active |
| J3265 | Injection, torsemide, 10 mg/ml | — | Jan 1, 1996 | Active |
| J3268 | Injection, delafloxacin, 1 mg | $0.478per 1 MG | Oct 1, 2026 | Active |
| J3280 | Injection, thiethylperazine maleate, up to 10 mg | — | Jan 1, 1982 | Ended Dec 31, 2025 |
| J3285 | Injection, treprostinil, 1 mg | $54.563per 1 MG | Jan 1, 2006 | Active |
| J3290 | Injection, tranexamic acid, 5 mg | — | Oct 1, 2025 | Active |
| J3291 | Injection, tranexamic acid in sodium chloride, 5 mg | — | Jan 1, 2026 | Active |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | $47.705per 1 MG | Jul 1, 2022 | Active |
| J3300 | Injection, triamcinolone acetonide (triesence), preservative free, 1 mg | $17.199per 1 MG | Jan 1, 2009 | Active |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mgNOC / NOS | $0.787per 10 MG | Jan 1, 1991 | Active |
| J3302 | Injection, triamcinolone diacetate, per 5 mg | — | Jan 1, 1991 | Active |
| J3303 | Injection, triamcinolone hexacetonide, per 5 mg | — | Jan 1, 1991 | Active |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | $19.159per 1 MG | Jan 1, 2019 | Active |
| J3305 | Injection, trimetrexate glucuronate, per 25 mg | — | Jan 1, 1996 | Ended Dec 31, 2025 |
| J3310 | Injection, perphenazine, up to 5 mg | — | Jan 1, 1982 | Ended Dec 31, 2025 |
| J3315 | Injection, triptorelin pamoate, 3.75 mg | $467.059per 3.75 MG | Jan 1, 2003 | Active |
| J3316 | Injection, triptorelin, extended-release, 3.75 mg | $3,830.439per 3.75 MG | Jan 1, 2019 | Active |
| J3320 | Injection, spectinomycin dihydrochloride, up to 2 gm | — | Jan 1, 1982 | Ended Dec 31, 2025 |
| J3350 | Injection, urea, up to 40 gm | — | Jan 1, 1986 | Active |
| J3355 | Injection, urofollitropin, 75 iu | — | Jan 1, 2006 | Ended Dec 31, 2025 |
| J3357 | Ustekinumab, for subcutaneous injection, 1 mg | — | Jan 1, 2011 | Active |
| J3358 | Ustekinumab, for intravenous injection, 1 mg | $10.249per 1 MG | Jan 1, 2018 | Active |
| J3360 | Injection, diazepam, up to 5 mg | $5.069per 5 MG | Jan 1, 1982 | Active |
| J3364 | Injection, urokinase, 5000 iu vial | — | Jan 1, 1993 | Ended Dec 31, 2025 |
| J3365 | Injection, iv, urokinase, 250,000 i.u. vial | — | Jan 1, 1992 | Ended Dec 31, 2025 |
| J3370 | Injection, vancomycin hcl, 500 mg | — | Jan 1, 1986 | Ended Jun 30, 2025 |
| J3371 | Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg | — | Jan 1, 2023 | Ended Jun 30, 2025 |
| J3372 | Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg | — | Jan 1, 2023 | Ended Jun 30, 2025 |
| J3373 | Injection, vancomycin hydrochloride, 10 mg | $0.032per 10 MG | Jul 1, 2025 | Active |
| J3374 | Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg | $0.091per 10 MG | Jul 1, 2025 | Active |
| J3375 | Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg | $0.143per 10 MG | Jul 1, 2025 | Active |
| J3376 | Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg | $0.016per 10 MG | Jan 1, 2026 | Active |
| J3379 | Injection, valproate sodium, 5 mg | $0.032per 5 MG | Jan 1, 2026 | Active |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | $20.949per 1 MG | Jan 1, 2016 | Active |
| J3385 | Injection, velaglucerase alfa, 100 units | $393.929per 100 UNITS | Jan 1, 2011 | Active |
| J3386 | Injection, etuvetidigene autotemcel, per treatment | — | Jul 1, 2026 | Active |
| J3387 | Injection, elivaldogene autotemcel, per treatment | — | Jan 1, 2026 | Active |
| J3389 | Topical administration, prademagene zamikeracel, per treatment | — | Jan 1, 2026 | Active |
| J3391 | Injection, atidarsagene autotemcel, per treatment | — | Jul 1, 2025 | Active |
| J3392 | Injection, exagamglogene autotemcel, per treatment | — | Jan 1, 2025 | Active |
| J3393 | Injection, betibeglogene autotemcel, per treatment | — | Jul 1, 2024 | Active |
| J3394 | Injection, lovotibeglogene autotemcel, per treatment | — | Jul 1, 2024 | Active |
| J3396 | Injection, verteporfin, 0.1 mg | $11.342per 0.1 MG | Jan 1, 2005 | Active |
| J3397 | Injection, vestronidase alfa-vjbk, 1 mg | — | Jan 1, 2019 | Active |
| J3398 | Injection, voretigene neparvovec-rzyl, 1 billion vector genomes | — | Jan 1, 2019 | Active |
| J3399 | Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes | — | Jul 1, 2020 | Active |
| J3400 | Injection, triflupromazine hcl, up to 20 mg | — | Jan 1, 1982 | Ended Dec 31, 2025 |
| J3401 | Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml | $1,029.469per 0.1 ML | Jan 1, 2024 | Active |
| J3402 | Injection, remestemcel-l-rknd, per therapeutic dose | $202,159.938per Per Therapeutic Dose | Oct 1, 2025 | Active |
| J3403 | Revakinagene taroretcel-lwey, per implant | — | Oct 1, 2025 | Active |
| J3404 | Injection, zopapogene imadenovec-drba suspension, per therapeutic dose | $119,675.512per Per Therapeutic Dose | Apr 1, 2026 | Active |
| J3405 | Injection, onasemnogene abeparvovec-brve, per treatment | $2,729,937.922per Per treatment | Jul 1, 2026 | Active |
| J3406 | Injection, omidubicel-onlv, per therapeutic dose | — | Oct 1, 2026 | Active |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg | $14.113per 25 MG | Jan 1, 1982 | Active |
| J3411 | Injection, thiamine hcl, 100 mg | $1.486per 100 MG | Jan 1, 2004 | Active |
| J3415 | Injection, pyridoxine hcl, 100 mg | $15.788per 100 MG | Jan 1, 2004 | Active |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | $0.648per 1000 MCG | Jan 1, 1986 | Active |
| J3424 | Injection, hydroxocobalamin, intravenous, 25 mg | — | Apr 1, 2024 | Active |
| J3425 | Injection, hydroxocobalamin, intramuscular, 10 mcg | $0.007per 10 MCG | Jan 1, 2024 | Active |
| J3430 | Injection, phytonadione (vitamin k), per 1 mg | $3.989per 1 MG | Jan 1, 1982 | Active |
| J3465 | Injection, voriconazole, 10 mg | $0.548per 10 MG | Jan 1, 2004 | Active |
| J3470 | Injection, hyaluronidase, up to 150 units | $31.802per 150 UNITS | Jan 1, 1982 | Active |
| J3471 | Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) | — | Jan 1, 2006 | Active |
| J3472 | Injection, hyaluronidase, ovine, preservative free, per 1000 usp units | — | Jan 1, 2006 | Active |
| J3473 | Injection, hyaluronidase, recombinant, 1 usp unit | $0.364per 1 USP UNIT | Jan 1, 2007 | Active |
| J3475 | Injection, magnesium sulfate, per 500 mg | $0.436per 500 MG | Jan 1, 1996 | Active |
| J3480 | Injection, potassium chloride, per 2 meq | $0.130per 2 MEQ | Jan 1, 1996 | Active |
| J3485 | Injection, zidovudine, 10 mg | $1.513per 10 MG | Jan 1, 2001 | Active |
| J3486 | Injection, ziprasidone mesylate, 10 mg | $5.940per 10 MG | Jan 1, 2004 | Active |
| J3489 | Injection, zoledronic acid, 1 mg | $17.673per 1 MG | Jan 1, 2014 | Active |
| J3490 | Unclassified drugsNOC / NOS | — | Jan 1, 1986 | Active |
| J3520 | Edetate disodium, per 150 mg | — | Jan 1, 1986 | Active |
| J3530 | Nasal vaccine inhalation | — | Jan 1, 1986 | Active |
| J3535 | Drug administered through a metered dose inhaler | — | Jan 1, 1994 | Active |
| J3570 | Laetrile, amygdalin, vitamin b17 | — | Jan 1, 1986 | Active |
| J3590 | Unclassified biologicsNOC / NOS | — | Jan 1, 2003 | Active |
| J3591 | Unclassified drug or biological used for esrd on dialysisNOC / NOS | — | Jan 1, 2019 | Active |
| J7030 | Infusion, normal saline solution , 1000 cc | $2.263per 1000 CC | Jan 1, 1982 | Active |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | $1.385per 500 ML | Jan 1, 1984 | Active |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | $1.265per 500 ML | Jan 1, 1984 | Active |
| J7050 | Infusion, normal saline solution, 250 cc | $0.717per 250 CC | Jan 1, 1982 | Active |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | $2.082per 500 ML | Jan 1, 1985 | Active |
| J7070 | Infusion, d5w, 1000 cc | $3.370per 1000 CC | Jan 1, 1982 | Active |
| J7100 | Infusion, dextran 40, 500 ml | — | Jan 1, 1982 | Active |